A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack

Completed · Phase 3

Conditions studied: Migraine

In brief

The purpose of this research study is to evaluate an investigational auto-injector system for delivering sumatriptan under the skin for a single migraine attack. The study could take approximately 5 weeks and will include about 3 office visits to the study doctor, the patient will be contacted every 2 weeks until the patient experiences a migraine and uses the auto-injector. The last visit will be done by a telephone follow-up call.

Key facts

Study ID
NCT00510419
Run by
Pfizer
People needed
73
Starts
2007-07-01
Expected to finish
2007-12-01
Last updated by the study team
2012-06-08

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.